NEW YORK (GenomeWeb) – Sysmex Inostics today announced that it has signed an exclusive distribution agreement with IndivuTest for the OncoBEAM test.

Under the terms of the agreement, IndivuTest will offer Sysmex Inostics' OncoBEAM laboratory-based test throughout Germany, Austria, and Switzerland. IndivuTest will be responsible for commercial and sample logistics, while Sysmex Inostics will perform all testing services at its CLIA laboratory in Baltimore.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The United Nations is to consider a ban on field testing gene drives at a meeting being held next week, Technology Review reports.

The Associated Press reports that gene-edited food may soon be for sale.

The US Department of Health and Human Services is beginning a series of meetings on human fetal tissue research, Stat News reports.

In Cell this week: epigenetic change linked to glioblastomas, rare and low-frequency variants contributing to multiple sclerosis risk, and more.